» Articles » PMID: 16200069

Maintenance of B Cell Anergy Requires Constant Antigen Receptor Occupancy and Signaling

Overview
Journal Nat Immunol
Date 2005 Oct 4
PMID 16200069
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Immunological tolerance can be mediated by anergy, in which self-reactive B cells persist in the periphery yet remain unresponsive to immunogen. Whether anergy is induced after transient exposure to self antigen and is 'remembered' or requires continuous antigen receptor occupancy and transduction of signals remains unclear. We have explored this using an immunoglobulin-transgenic mouse in which B cells were hapten specific (arsonate) yet cross-reacted with a self antigen that induced anergy in vivo. Many features of anergic cells were rapidly reversed after dissociation of self antigen using hapten competition and these cells regained antigen responsiveness. Our findings indicate that continuous binding of antigen and subsequent receptor signaling are essential for the maintenance of anergy.

Citing Articles

The role of B cells in the pathogenesis of type 1 diabetes.

Wang Y, Li R, Huang Y, Chen H, Nie H, Liu L Front Immunol. 2025; 15():1450366.

PMID: 39776900 PMC: 11703732. DOI: 10.3389/fimmu.2024.1450366.


Therapeutic induction of antigen-specific immune tolerance.

Kenison J, Stevens N, Quintana F Nat Rev Immunol. 2023; 24(5):338-357.

PMID: 38086932 PMC: 11145724. DOI: 10.1038/s41577-023-00970-x.


Identification of an anergic BND cell-derived activated B cell population (BND2) in young-onset type 1 diabetes patients.

Stensland Z, Magera C, Broncucia H, Gomez B, Rios-Guzman N, Wells K J Exp Med. 2023; 220(8).

PMID: 37184563 PMC: 10192302. DOI: 10.1084/jem.20221604.


Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities.

Wang H, Lin S, Wu X, Jiang K, Lu H, Zhan C Adv Sci (Weinh). 2023; 10(20):e2301777.

PMID: 37150860 PMC: 10369250. DOI: 10.1002/advs.202301777.


CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells.

Zheng Y, Yu M, Chen Y, Xue L, Zhu W, Fu G J Immunol. 2023; 210(9):1222-1235.

PMID: 36961449 PMC: 10156913. DOI: 10.4049/jimmunol.2200639.